-WSS

author：leisure time 2025-08-26 10:55:30 - browse：12

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Congress gives doctors Medicare pay bump

focus

WSS

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Elevance, private equity launch primary care company

Steward Health Care files for bankruptcy

Readout LOUD podcast: What to know about H5N1 bird flu

After gene therapy, two congenitally deaf children hear for the first time

Dairy farmers resist CDC push for PPE against bird flu virus

focus

leisure time

Hollywood unions extend contract negotiations for actors

Covid isolation guidance eased by the CDC

After affirmative action ruling, medical educators look to 'holistic review'

Clinical trials giant ICON acquires HumanFirst

Hepatitis C has a cure — but many Americans still lack access to it

FogPharma raises $145 million in rare Series E round

The high cost of giving birth even with insurance

Why getting cancer drugs just got harder for rural patients

Medicare details structure of new drug price negotiation program

Obesity now affects over 1 billion people worldwide, study finds

hotspot

Readout LOUD podcast: What to know about H5N1 bird flu

Brain worms: The science behind RFK Jr.'s parasitic infection

How to improve immunocompromised access to mAb treatments

CDC wastewater surveillance dashboard to track bird flu hotspots

House looks to weaken Medicare negotiation

After gene therapy, two congenitally deaf children hear for the first time

focus

hotspot

hotspot

hotspot